SCHEMBL4039638

SCHEMBL4039638

O=c1onc(-c2[c]non2)n1-c1ccc(F)c(Br)c1

nearest known ligand 0.46

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30628067 0.78 IDO1 (0.51) IDO1
SCHEMBL29099152 0.78 IDO1 (0.51) IDO1
SCHEMBL30141307 0.77 IDO1 (0.44) IDO1
SCHEMBL123581 0.76 IDO1 (0.54) IDO1
SCHEMBL29376679 0.76 IDO1 (0.54) IDO1
SCHEMBL21236133 0.76 IDO1 (0.52) IDO1
SCHEMBL21236453 0.74 IDO1 (0.51) IDO1
SCHEMBL30100166 0.74 IDO1 (0.51) IDO1
SCHEMBL30628110 0.74 IDO1 (0.53) IDO1
SCHEMBL29099091 0.74 IDO1 (0.53) IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110139857-B Sulfoximine, sulfoximinamide, sulfodiimine, and diimine sulfonamide compounds as indoleamine 2,3-dioxygenase inhibitors 重庆复尚源创医药技术有限公司 2023-07-21 — — CN disclosed
US-8466275-B2 Method for the preparation of 2-halo-2′-deoxyadenosine compounds from 2′-deoxyguanosine BRIGHAM YOUNG UNIVERSITY (US) 2013-06-18 — — US disclosed
EP-1556400-B1 METHOD FOR THE PREPARATION OF 2-HALO-2 -DEOXYADENOSINE COMPOUNDS FROM 2 -DEOXYGUANOSINE UNIV BRIGHAM YOUNG (US) 2013-05-01 — — EP disclosed
US-20090270604-A1 METHOD FOR THE PREPARATION OF 2-HALO-2'-DEOXYADENOSINE COMPOUNDS FROM 2'-DEOXYGUANOSINE BRIGHAM YOUNG UNIVERSITY 2009-10-29 — — US disclosed
US-7572909-B2 Method for the preparation of 2-halo-2′-deoxyadenosine compounds from 2′-deoxyguanosine BRIGHAM YOUNG UNIVERSITY (US) 2009-08-11 — — US disclosed
EP-1879573-A4 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF USING THE SAME INCYTE CORP (US) 2009-07-08 — — EP disclosed
EP-1879573-A1 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF USING THE SAME Incyte Corporation (US) 2008-01-23 — — EP disclosed
US-20070032645-A1 Method for the preparation of 2-halo-2'-deoxyadenosine compounds for 2'-deoxyguanosine BRIGHAM YOUNG UNIVERSITY (US) 2007-02-08 — — US disclosed
WO-2006122150-A1 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF USING THE SAME INCYTE CORPORATION (US) 2006-11-16 — — WO disclosed
EP-1556400-A2 METHOD FOR THE PREPARATION OF 2-HALO-2 -DEOXYADENOSINE COMPOUNDS FROM 2 -DEOXYGUANOSINE Brigham Young University (US) 2005-07-27 — — EP disclosed
WO-2004028462-A2 METHOD FOR THE PREPARATION OF 2-HALO-2'-DEOXYADENOSINE COMPOUNDS FROM 2'-DEOXYGUANOSINE BRIGHAM YOUNG UNIVERSITY, TECHNOLOGY TRANSFER OFFICE (US) 2004-04-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032645-A1 Method for the preparation of 2-halo-2'-deoxyadenosine compounds for 2'-deoxyguanosine DCTD, CDA, UNG IDO1 2511/4885
US-20090270604-A1 METHOD FOR THE PREPARATION OF 2-HALO-2'-DEOXYADENOSINE COMPOUNDS FROM 2'-DEOXYGUANOSINE DCTD, CDA, UNG IDO1 2446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback